Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 5/20 | 0.82 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.82 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.82 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.82 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.82 |
| ▸ | MEN1 | O00255 | 2/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.82 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.82 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.82 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.82 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.82 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.57 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | JUN | P05412 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7743553 | 1.00 | CHRNB2 (0.82) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL5701137 | 1.00 | CHRNB2 (0.82) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| Rivanicline SCHEMBL120435 | 0.90 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| Rivanicline SCHEMBL29379231 | 0.90 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| Rivanicline SCHEMBL7743987 | 0.90 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| Rivanicline SCHEMBL29423002 | 0.90 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| Rivanicline SCHEMBL120434 | 0.90 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| Rivanicline SCHEMBL6260928 | 0.82 | CHRNB2 (0.83) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| Rivanicline SCHEMBL29615748 | 0.82 | CHRNB2 (0.83) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL7520275 | 0.82 | CHRNB2 (0.64) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0801527-B1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | TARGACEPT INC (US) | 2006-07-26 | — | — | EP | disclosed |
| EP-1011672-B1 | USE OF (E)-METANICOTINE DERIVATIVES FOR ELICITING ANALGESIC EFFECTS | UNIV VIRGINIA COMMONWEALTH (US) | 2005-10-19 | — | — | EP | disclosed |
| EP-0873050-B1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF ULCERATIVE COLITIS | TARGACEPT INC (US) | 2004-03-10 | — | — | EP | disclosed |
| EP-0801527-A4 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | REYNOLDS TOBACCO CO R (US) | 2001-09-05 | — | — | EP | disclosed |
| US-6107298-A | ADMINISTERING AN AMINE SUBSTITUTED PYRIMIDINE OR PYRIDINE COMPOUND | BENCHERIF MEROUANE (US) | 2000-08-22 | — | — | US | disclosed |
| EP-0873050-A4 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF ULCERATIVE COLITIS | REYNOLDS TOBACCO CO R (US) | 1999-09-22 | — | — | EP | disclosed |
| US-5885998-A | ADMINISTERING AN EFFECTIVE AMOUNT OF AN ARYL SUBSISTITUTED ALIPHATIC COMPOUND, AN ARYL SUBSTITUTED OLEFINIC AMINE COMPOUND OR AN ARYL SUBSTITUTED ACETYLENIC COMPOUND SUCH AS 4-(5-PYRIMIDINYL)-3-BUTENE-1-AMINE | TARGACEPT, INC., A CORPORATION OF DELAWARE | 1999-03-23 | — | — | US | disclosed |
| EP-0873050-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF ULCERATIVE COLITIS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1998-10-28 | — | — | EP | disclosed |
| US-5824692-A | AMINOPYRIDINE, AMINOPYRIMIDINE DERIVATIVES | TARGACEPT, INC. | 1998-10-20 | — | — | US | disclosed |
| EP-0801646-A4 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | REYNOLDS TOBACCO CO R (US) | 1998-03-25 | — | — | EP | disclosed |
| US-5731314-A | ADMINISTERING ARYL SUBSTITUTED OLEFINIC AMINE COMPOUNDS OR ARYL SUBSTITUTED ACETYLENIC AMINE COMPOUNDS TO A PATIENT | TARGACEPT, INC., A CORPORATION OF DELAWARE | 1998-03-24 | — | — | US | disclosed |
| US-5726316-A | PYRIDINYL DERIVATIVES WITH 3-BUTENE-1-AMINE | TARGACEPT, INC. | 1998-03-10 | — | — | US | disclosed |
| EP-0801646-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1997-10-22 | — | — | EP | disclosed |
| EP-0801527-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1997-10-22 | — | — | EP | disclosed |
| US-5616707-A | N-METHYL-4-PYRIDYL-3-BUT(ENE OR YNE)-1-AMINE | TARGACEPT, INC. | 1997-04-01 | — | — | US | disclosed |
| US-5604231-A | NON-STEROIDAL ANTIINFLAMMATORY AGENTS, DOPAMINERGIC AGENTS; SIDE EFFECT REDUCTION | TARGACEPT, INC. | 1997-02-18 | — | — | US | disclosed |
| US-5597919-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS RESULTING FROM NEUROTRANSMITTER DYSFUNCTION | TARGACEPT, INC., A CORPORATION OF DELAWARE | 1997-01-28 | — | — | US | disclosed |
| WO-1996020929-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1996-07-11 | — | — | WO | disclosed |
| WO-1996020599-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF ULCERATIVE COLITIS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1996-07-11 | — | — | WO | disclosed |
| WO-1996020600-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1996-07-11 | — | — | WO | disclosed |